Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromocriptine plus metformin in type 2 diabetes mellitus
CTR20150004Phase 3Suspended
- Sponsor
- Hengrui Therapeutics
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bromocriptine in type 2 diabetes mellitus (T2DM), sponsored by Hengrui Therapeutics. Started Jan 2015; status: suspended.
02
Drugs
bromocriptine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20150004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150004.